Metformin is typically the therapy of choice for patients with prediabetes, but GLP-1 drugs appear to offer several benefits.

Two lots of a generic blood pressure medication were recalled because the drugs may be ineffective. The FDA ruled this as a Class II recall. 

“We expected that the chances of heart disease would gradually rise as people used cannabis more often, but that wasn’t the case," one researcher said. "Both low-use and heavy-use groups had higher odds of developing heart disease."

Researchers reviewed an FDA safety database, finding that these products were commonly involved in reports related to cardiac arrest, heart attacks, ventricular arrhythmias, heart palpitations, chest pain and fainting.

TAVR may be a safe, effective treatment strategy for patients with moderate aortic stenosis and at least one other warning sign of heart disease. That was the key takeaway from a highly anticipated late-breaking study presented by Philippe Généreux, MD, at TCT 2026 in San Diego. 

Implementing advanced AI models into daily practice takes much more than simply installing software. It requires a clinical champion and multiple stakeholders to coordinate the effort.

Men are much more likely to have degenerative mitral valve disease than men, according to a new global analysis presented at TCT 2026 in San Diego. However, women are more likely to die from it. 

The upfront costs may be higher, but new data presented at TCT 2026 showed that treating asymptomatic patients with TAVR instead of clinical surveillance was a highly cost-effective intervention. 

William Holding, a veteran healthcare consultant, spoke to Cardiovascular Business about the ever-changing cardiology industry. Should private practices seek a deal or stay independent? How has private equity impacted the market? He answered those questions and many more. 

Rick Snyder, MD, president of the Cardiac PET Alliance, says PET offers better images than SPECT and is associated with much less radiation.

The ACC, SCAI and STS have shared early support for expanding Medicare coverage to include TAVR in patients with native AR. The groups emphasized that CED requirements and multidisciplinary heart team meetings are necessary to ensure patients receive the best possible care going forward.

A lead-free, ceiling-mounted shielding system could significantly reduce occupational radiation exposure among physicians performing fluoroscopy-guided procedures, according to a study presented at TCT 2026. 

In an open letter, the American Hospital Association and American Medical Association, among others, are asking regulators to delay the rollout of the Ambulatory Specialty Model, a value-based reimbursement structure for patients with heart failure and lower back pain.